Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema

Current Eye Research

Volumn 37, Issue 12, 2012, Pages 1165-1170

  Sevim, Mehmet Sahin ^a   Sanisoglu, Hüseyin ^a   Turkyilmaz, Kemal ^b  

^a Department of Otorhinolaryngology/Head and Neck Surgery   (Turkey)

^b RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

Intravitreal triamcinolone acetonide; Pars plana vitrectomy; Pseudophakic cystoid macular edema

Indexed keywords

TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; CATARACT EXTRACTION; CILIARY DISK; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; OPHTHALMOLOGY; PARS PLANA VITRECTOMY; PRIORITY JOURNAL; PSEUDOPHAKIC CYSTOID MACULAR EDEMA; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; VISUAL ACUITY; VITRECTOMY;

AGED; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; PSEUDOPHAKIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITRECTOMY;

EID: 84870276602     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.721444     Document Type: Article

References (34)

1. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol 2002;17:167-180. (Pubitemid 36514801)
2. Ching HY, Wong AC, Wong CC et al. Cystoid macular oedema and changes in retinal thickness after phacoemul-sifcation with optical coherence tomography. Eye (Lond) 2006;20:297-303.
3. Ursell PG, Spalton DJ, Whitcup SM et al. Cystoid macular edema after phacoemulsifcation: Relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg 1999;25:1492-1497. (Pubitemid 29523175)
4. Flach AJ. The incidence, pathogenesis and treatment of cys-toid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998;96:557-634. (Pubitemid 29012928)
5. Catier A, Tadayoni R, Paques M et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 2005;140:200-206.
6. Tranos PG, Wickremasinghe SS, Stangos NT et al. Macular edema. Surv Ophthalmol 2004;49:470-490. (Pubitemid 39504763)
7. Conway MD, Canakis C, Livir-Rallatos C et al. Intravitreal triamcinolone acetonide for refractory chronic pseudo-phakic cystoid macular edema. J Cataract Refract Surg 2003;29:27-33. (Pubitemid 36152276)
8. Rho DS. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac. J Cataract Refract Surg 2003;29:2378-2384. (Pubitemid 38049737)
9. Steinert RF, Wasson PJ. Neodymium:YAG laser anterior vit-reolysis for Irvine-Gass cystoid macular edema. J Cataract Refract Surg 1989;15:304-307. (Pubitemid 19142822)
10. Harbour JW, Smiddy WE, Rubsamen PE et al. Pars plana vit-rectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 1995;120:302-307.
11. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003;136:384-386. (Pubitemid 36904101)
12. Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal triam-cinolone acetonide for the treatment of chronic pseudo-phakic cystoid macular oedema. Acta Ophthalmol Scand 2003;81:648-652. (Pubitemid 37527645)
13. Lewis H, Abrams GW, Blumenkranz MS et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-759.
14. Patel JI, Hykin PG, Schadt M et al. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina (Philadelphia, Pa) 2006;26:5-13. (Pubitemid 44391745)
15. Kamura Y, Sato Y, Isomae T et al. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients. Jpn J Ophthalmol 2005;49:297-300. (Pubitemid 41264805)
16. Flach AJ, Jampol LM, Weinberg D et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991;112:514-519.
17. Tripathi RC, Fekrat S, Tripathi BJ et al. A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy. Ann Ophthalmol 1991;23:127-129.
18. Shelsta HN, Jampol LM. Pharmacologic therapy of pseu-dophakic cystoid macular edema:2010 update. Retina (Philadelphia, Pa) 2011;31:4-12.
19. Arevalo JF, Maia M, Garcia-Amaris RA et al.; Pan-American Collaborative Retina Study Group. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: The Pan-American Collaborative Retina Study Group results. Ophthalmology 2009;116:1481-7, 1487.e1.
20. Norregard JC, Bernt-Petersen P, Bellan L et al. Intraoperative clinical practice of risk of early complications after cataract extraction in United States, Canada, Denmark and Spain. Ophthalmology 1999;106:42-48.
21. Solomon LD. Effcacy of topical furbiprofen and indometh-acin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I. J Cataract Refract Surg 1995;21:73-81.
22. Fung WE. Vitrectomy for chronic aphakic cystoid macular edema. Results of a national, collaborative, prospective, randomized investigation. Ophthalmology 1985;92:1102-1111. (Pubitemid 15227427)
23. Fung WE. The national, prospective, randomized vitrectomy study for chronic aphakic cystoid macular edema. Progress report and comparison between the control and nonrandom-ized groups. Surv Ophthalmol 1984;28 Suppl:569-575. (Pubitemid 14076517)
24. Pendergast SD, Margherio RR, Williams GA et al. Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 1999;128:317-323. (Pubitemid 29413228)
25. Koutsandrea C, Moschos MM, Brouzas D et al. Intraocular triamcinolone acetonide for pseudophakic cystoid macu-lar edema: Optical coherence tomography and multifo-cal electroretinography study. Retina (Philadelphia, Pa) 2007;27:159-164.
26. Rhee DJ, Peck RE, Belmont J et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol 2006;90:999-1003. (Pubitemid 44140181)
27. Peyman GA, Canakis C, Livir-Rallatos C et al. The effect of internal limiting membrane peeling on chronic recalcitrant pseudophakic cystoid macular edema: A report of two cases. Am J Ophthalmol 2002;133:571-572. (Pubitemid 34258075)
28. Jin MA, Ke YAO. 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion. Retina 2008;28:947-956.
29. Otani T, Kishi S. A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 2002;134:214-219. (Pubitemid 34831825)
30. Stefánsson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31:284-289. (Pubitemid 20072693)
31. Grant MB, Mames RN, Fitzgerald C et al. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: Comparative studies with basic fbroblast growth factor. Diabetologia 1993;36:282-291. (Pubitemid 23106010)
32. Mason JO 3rd, Albert MA Jr, Vail R. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina (Philadelphia, Pa) 2006;26:356-357. (Pubitemid 44318197)
33. Barone A, Russo V, Prascina F et al. Short-term safety and effcacy of intravitreal bevacizumab for pseudophakic cys-toid macular edema. Retina (Philadelphia, Pa) 2009;29:33-37.
34. Warren KA, Bahrani H, Fox JE. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. Retina (Philadelphia, Pa) 2010;30:260-266.